MedPage Today on MSN
Drug Cuts Albuminuria in Type 1 Diabetic Kidney Disease, Too
First new drug in 30 years to slow kidney disease in type 1 diabetes ...
Detailed price information for Bridgebio Pharma Inc (BBIO-Q) from The Globe and Mail including charting and trades.
In this Q&A, lead author Dr. Nanfang Pan explains how researchers used structural MRI, normative brain modeling, and machine learning to identify three ADHD biotypes. Each subtype showed distinct ...
Short sleep phenotype appears to drive excess cardiovascular risk in patients with comorbid insomnia and obstructive sleep apnea symptoms.
MedPage Today on MSN
Bimekizumab Safety Holds Up in Long-Term Data
Pooled data from PsA and axSpA extension studies provide early reassurance ...
Obviously there is some overlap between the two arguments and they both boil down to: “Normal people” do not have the resources needed to understand the world around them, either because of financial ...
Widespread adoption of the SWIFT approach, which reduces the number of clinic visits in the acute phase by ~70%, could alter how interventional psychiatry is delivered, improving patient retention and ...
Israeli strike of February 28, 2026, that killed Khamenei was full-spectrum corporate warfighting. India watched. It must now evolve ...
A therapy approach that changes how people relate to their thoughts may help address one of the fastest-growing drivers of sick leave.
News-Medical.Net on MSN
Weekend lie-ins may boost insulin sensitivity, but too much may backfire
By Dr. Liji Thomas, MD New research suggests sleeping a little longer on weekends may help people who cut their sleep short ...
New presentations for tildrakizumab-asmn explore real-world use in U.S. patients using Medicare New data specific to patients with skin of color expands ...
A large longitudinal study of U.S. adults found that many older people improve in cognitive function or walking speed over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results